Market Access

HTAnalyze supports organizations in critical market access, pricing, and value demonstration projects by integrating clinical evidence, HEOR (Health Economics and Outcomes Research), budget impact analysis, and RWE (Real-World Evidence) into robust, transparent, and traceable deliverables. We operate extensively across key healthcare decision-making pathways in Brazil, including Conitec, ANS, and CMED, and support clients in navigating regulatory, reimbursement, and incorporation processes.

Market Access – Brazil

Conitec (SUS) Submissions

We develop Conitec submissions with methodological rigor and complete deliverables, integrating clinical evidence, economic evaluation, and budget impact analysis to support decisions within the SUS, the Brazilian public health system.

Useful information and links

Public consultations: analysis and technical contributions

We support companies and institutions in building consistent contributions and responses, with a clear narrative, scientific backing, and strategic positioning.

Get in touch

Preliminary assessment of submission feasibility

We mapped the scenario and maturity of the dossier to guide the decision: submit, supplement evidence, or revise strategy.

Get in touch

ANS Submissions for the List of Procedures and Health Events

We structure dossiers and analyses for submissions to the ANS (Brazilian National Agency for Supplementary Health), with methodological rigor, clarity in the value proposition, and alignment with regulatory deadlines.

Useful information and links

CMED Price Dossier

We structure CMED price dossiers with technical and documentary consistency, integrating references, comparators, and justifications in accordance with regulations.

Get in touch

Submission Support and Technical Defense

We offer comprehensive support for technical submission and defense, including technical forms such as FormRol, presentation preparation, strategic alignment, and support in conducting meetings with decision-making committees.

Get in touch